Form 4: Wan Long Increases Smithfield Stake to 5.06M Shares
Rhea-AI Filing Summary
Insider purchase reported: Wan Long, a director of Smithfield Foods, Inc. (SFD), purchased 1,800,000 shares of common stock on 09/08/2025 at a price of $23.25 per share. After the transaction Wan Long beneficially owned 5,060,000 shares. The Form 4 was signed by an attorney-in-fact on 09/09/2025.
Positive
- Director purchase of 1,800,000 shares reported, increasing the director's stake to 5,060,000 shares
- Transaction disclosed under Section 16 with a clear price of $23.25 per share and dated transaction information
Negative
- None.
Insights
TL;DR: A director-level purchase of 1.8M shares at $23.25 increases insider stake to 5.06M shares, signaling a material insider buy.
The filing documents a direct acquisition by Wan Long on 09/08/2025 of 1,800,000 common shares at $23.25, bringing beneficial ownership to 5,060,000 shares. This is a clear insider purchase disclosed under Section 16; the size of the transaction is significant on an absolute basis as reported. The disclosure is routine in form and contains no derivatives or dispositions.
TL;DR: Director Wan Long completed a substantial open-market or private purchase; reporting appears complete and timely.
The Form 4 indicates Wan Long is listed as a director and filed as a single reporting person. The form shows a non-derivative acquisition only, with no joint filers or related derivative activity disclosed. The form is executed via attorney-in-fact; signature and filing details are present. No additional governance actions or plan-based purchases are disclosed.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock, no par value | 1,800,000 | $23.25 | $41.85M |
FAQ
What did Wan Long report on the Form 4 for Smithfield Foods (SFD)?
Was the Form 4 filed jointly or by one reporting person?
Does the Form 4 show any derivative transactions or dispositions?
Who signed the Form 4 and when?
What was the role of the reporting person at the issuer?
AI-generated analysis. How Rhea-AI works. Not financial advice.